San Francisco Biotech Networks’ Post

SFBN Feed: Another step toward new drugs for Parkinson’s https://lnkd.in/gyrmUE8q Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with the plight of… Click here to view original [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

Meet the Inaphaea commercial team. We are led by science, but backed by deep commercial understanding, and appreciate the challenges faced by drug developers and aim to address a clear gap in the market. This is thanks to the strength of our commercial team which combines business acumen and experience with scientific expertise. Get to know Dr Andrew Carnegie, Dr Mark Eccleston and Dr Gareth Griffiths in our latest blog, and find out what they have to say about the company’s ongoing growth: https://lnkd.in/ewwu-csU #Assays #AssayDevelopment #BioTech #DrugDiscovery #CancerResearch #ScientificResearch

SFBN Feed: STAT+: Pharmalittle: We’re reading about Sanofi’s Olympics bet, Singulair problems, and more https://lnkd.in/g4CEvUhS A 2020 FDA warning on the labeling that Singulair could cause aggression, agitation, and suicidal thoughts barely dented use. Click here to view original post #BayArea #SanFrancisco #Biotech #Lifescience #News

Unlock the potential of bioanalytics with advanced technologies and techniques. Discover how to develop and validate methods that meet regulatory requirements, and how to tackle the most complex challenges. Access our curated series of technical content to make the most of your research. Achieve unprecedented levels of sensitivity—learn how 👇 https://bit.ly/3N6GwbD #Bioanalysis #SCIEX #DrugDiscovery

Exciting times! We are thrilled to be meeting our partners and exploring new innovative technologies in the world of #Biotechnology, #AnalyticalChemistry, and #LabTechnology! Reach out to NIRMAL KUMAR M and myself for a quick meeting during analytica! #Innovation #Middleeast #Analytica #Tradeshow

People make more patient decisions when shown the benefits first https://lnkd.in/ggyhf_3h The post People make more patient decisions when shown the benefits first appeared first on Life Sciences. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News

👀 Here's an eye-opening juxtaposition of large-molecule therapeutic engineering. 🚧 I just wrapped a #businessofbiotech podcast recording with Skye Bioscience Inc. leader Punit Dhillon. Among other things, we discussed the inherent advantage of the company's CB 1-targeting antibody in obesity. Namely, because it's a large molecule, it can't cross the blood-brain barrier and thus, isn't likely to incite the CNS-related side effects we've seen in so many small molecule obesity drugs. 🔓 On the other hand, we have this fresh Bioprocess Online column from Tyler Menichiello featuring Aliada Therapeutics CSO John Dunlop. He explains why his company is engineering an end-around approach to getting large molecules INTO the CNS, BY WAY OF the blood-brain barrier. This, he says, could change the standard (and unpleasant) intrathecal bolus injection approach to getting #biologics to the brain for CNS disorders. Sometimes nature's rules enable favorable outcomes. Other times, we have to bend those rules to create favorable outcomes.

Mark your calendars for Drug Discovery Chemistry 2024! 📅 Join our President of Americas, Marc Neglia, from April 1st to 4th, 2024, at the Hilton Bayfront in San Diego, USA. We look forward to meeting you and discussing how we can help with your small molecule characterisation! Learn More: https://lnkd.in/e5QXzWSw #DrugDiscoveryChemistry #SmallMoleculeCharacterisation #ProteinStability

One of our biggest research questions is periodicity – that is, how often and over what period of time, is #celltherapy with the proprietary investigational product we study (HB-adMSCs) most effective? Listen in to clinicians David and Sherry, then catch the full episode at https://lnkd.in/gKSE5-Qi #biotech #research #hope

In 2024, the #biotech sector finds itself at a pivotal point, characterized by accelerated advancements and evolving market dynamics. This edition of Seamless Clinical Insights explores the current biotech atmosphere, highlighting opportunities for this year and beyond. #Subscribe to our newsletter today to gain actionable insights for your journey to clinical success: https://bit.ly/3WDYh5F